tirzepatide weight loss maximum typical Adults with obesity using maintain 'remarkable' at 88 weeks How to Break a Stall

It may also appeal to patients who are newer to GLP-1 medications and want a well-established medication pathway before considering a more potent dual-action option

Clinical insight: Most people reading this arent truly choosing between medicationstheyre trying to fix stalled fat loss, insulin resistance, or visceral fat that hasnt responded to diet, exercise, or even GLP-1 therapy alone

Planning for it is essential

This is when the hormonal signals are strongest and when the body is under the most significant metabolic pressure

Nausea, the most commonly reported side effect, typically peaks during dose escalation and then subsides within 1 to 2 weeks at the new dose level